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Not Your Typical Pneumonia
Shama Patel D.O., Scott Sipp, MD, Emergency Medicine,
Henry Ford Health System, Detroit, Michigan

Introduction
Diffuse alveolar hemorrhage (DAH) is the process of bleeding into the alveolar
spaces of the lungs due to disruption of the alveolar-capillary basement
membrane. It can be caused by many disease processes, including rheumatic
diseases, vasculitis, infection, drugs, etc4. DAH is a rare, but serious pulmonary
complication of systematic lupus erythematosus1. Cough, hemoptysis, fever, and
dyspnea are common initial symptoms, however, hemoptysis can be absent in up
to one third of patients3. In the absence of hemoptysis, new radiographic
opacities, decreasing hemoglobin level, and the finding of hemorrhagic fluid on
bronchoalveolar lavage favor the diagnosis5.

Case Presentation
CC: “Persistent fever, rash, cough”
HPI: 22 year old female G1P0 14 weeks pregnant is presenting to the ED with
chief complaint of fevers, body aches, lesions on the hand and in the mouth x2
weeks. Patient states that she was diagnosed with hand-foot-mouth disease, 12
days ago, states that since then has been having high fevers. Patient denies any
severe headaches, neck pain, chest pain, shortness of breath. Patient is a current
tobacco abuser. Patient denies any drug use or alcohol abuse. Patient has no
other medical problems. Followed up with her Ob two days ago, US of baby wnl
per patient. Patient denies having any abdominal cramping or vaginal bleeding or
discharge.
ROS: Positive for fatigue, myalgia, fevers, rash, cough
Vitals: BP 112/62 mmHg | Pulse 142 | 39.9ºC | RR 20 | SpO2 100%
Physical Examination:
Constitutional: Well-developed and well-nourished. Alert.
Eyes: Pupils are equal, round, and reactive to light. EOM are normal.
Throat: Pustules noted over roof of mouth
Neck: Normal range of motion and full passive range of motion without pain. No
neck rigidity.
Cardiovascular: Tachycardia, no murmurs
Pulmonary/Chest: Effort normal and breath sounds normal. No respiratory
distress.
Abdominal: Soft. Bowel sounds are normal. She exhibits no distension. There is
no tenderness. There is no rebound and no guarding.
Musculoskeletal: Normal range of motion.
Neurological: AAOX3. 5/5 strength B/L UE and LE. No cranial nerve deficit.
Negative finger to nose test
Skin: Pustules/erythematous lesion noted on palms of bilateral hands, elbows,
and lesions surrounding chin, on face, no evidence of sloughing of skin, no signs
of burns noted

Hospital Course
Henry Ford Macomb ED Course 10/13/2018:
On initial presentation, a code sepsis was called based on presenting vitals –
blood cultures, UA, CBC, BMP, Coags, CXR, lactic acid, influenza,
monospot, and strep culture were ordered. 30 cc/kg fluid bolus and Tylenol
was ordered.
Labs significant for:
WBC: 3.3 Hgb: 8.3 Lactic Acid: 2.7 Na:129 K: 3.1
Patient initially improved clinically, lactic acid cleared after fluid bolus,
however during the ED course, patient became hypoxic on room air at 88%,
improved with 2 L of oxygen when sitting upright, patient felt short of breath
lying flat, patient had bilateral coarse breath sounds, worse on the right, chest
x-ray was repeated, BNP and troponin obtained. Patient's repeat chest x-ray
showed worsening right lung interstitial pattern, concerns for pneumonia, at
this time sepsis identified, IV Rocephin and IV azithromycin were started and
patient was admitted for further evaluation.
Henry Ford Macomb Hospital Course 10/14/18-10/15/2018:
Patient continued to have recurrent fevers and tachycardia, repeat troponin
was ordered, elevated at 110, peaked at 250 then trended down, likely
secondary to NSTEMI type 2. ECHO 10/14/18 : EF: 57%. No evidence of
ischemic, valvular, hypertrophic, or pulmonary heart disease.

17:48
Rapid response is called for tachypnea and tachycardia, patient was febrile
102.8F, HR 130s-140, blood pressure stable, sinus tachycardia on EKG,
patient complained of positional chest pain at that time, patient was
transferred to the ICU for further monitoring.
10/15/18
Per ID notes, there was concern for disseminated zoster as patient was not
improving on antibiotics, started on acyclovir. Due to patient being a high risk
pregnancy, with worsening respiratory status, requiring HFNC – decision was
made to transfer to Henry Ford Main

Henry Ford Main Hospital Course:
Patient was transferred to HF Main MICU for escalation of care on 10/15/18. A
multidisciplinary approach was taken with ID, Rheumatology, Dermatology,
Nephrology, Hematology, and Maternal Fetal Medicine. Skin biopsies were
collected, with samples positive for cutaneous lupus, patient was started
on Methylprednisone 1g x 3 days and then Prednisone 70mg. Patient’s
respiratory status deteriorated, she was intubated on 10/17/18. Bronchoscopy on
10/18/18 demonstrated diffuse alveolar hemorrhage – six rounds of
plasmapheresis were completed. Given the patient’s severe symptoms
secondary to SLE, Cytoxan therapy was initiated along with prophylactic
Bactrim. Patient was cleared for discharge home with close follow up with her
OB/Gyn and Rheumatology team.
Throughout the hospital course, patient had an extensive immunological,
hematological, and infectious work up, which was all negative except the
following: ANA 1:640 speckled, low complements C3 and C4, RNP +, Smith+,
DAT+ Mycoplasma IgG

Discussion
DAH is a difficult diagnosis; clinical suspicion needs to be high. DAH
accounts for only for 1.5 to 3.7% of hospital admission due to SLE2. In this
particular case, when you look at the presentation of this patient, it classically
fits DAH. The patient appeared to have pneumonia, however, clinical
symptoms were not improving with antibiotics and continued to have
infiltrates on imaging, her skin biopsies and lab work was consistent with
SLE, and her BAL revealed hemorrhage fluid. This case was particularly
difficult, as patient did not present with hemoptysis, she did not have a known
diagnosis of SLE, she was pregnant, and had a complicated clinical course.
DAH has a high mortality rate, 25-50%, therefore, it is imperative to
diagnosis and treat early4. Treatment for DAH related to SLE includes a
combination of systemic glucocorticoids and immunosuppressive therapy,
rituximab, or plasmapheresis, and support care3.
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